RECURRENT BLADDER CARCINOMA
Clinical trials for RECURRENT BLADDER CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT BLADDER CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT BLADDER CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets rare bladder cancer mutations in small trial
Disease control OngoingThis study tests a drug called sapanisertib in 17 people with advanced bladder cancer that has a specific change in the TSC1 or TSC2 gene. The drug works by blocking a protein that helps cancer cells grow. The main goal is to see if the drug can shrink tumors or stop them from gr…
Matched conditions: RECURRENT BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Cancer treatment revolution: genetic testing paves the way for personalized therapy
Knowledge-focused OngoingThis study looks at whether matching cancer treatment to a patient's unique tumor genes works better than standard care. Over 6,400 adults with advanced cancers that no longer respond to treatment will have their tumors genetically tested. Based on the results, they receive a tar…
Matched conditions: RECURRENT BLADDER CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:05 UTC